06:48 AM EDT, 07/29/2025 (MT Newswires) -- Merck ( MRK ) reported Q2 non-GAAP earnings Tuesday of $2.13 per diluted share, down from $2.28 a year earlier.

Analysts polled by FactSet expected $2.02.

Sales for the quarter ended June 30 were $15.81 billion, compared with $16.11 billion a year earlier.

Analysts surveyed by FactSet expected $15.9 billion.

The company said it now expects 2025 adjusted EPS of $8.87 to $8.97, compared with its prior outlook range of $8.82 to $8.97. Analysts surveyed by FactSet expect $8.86.

Merck ( MRK ) now projects full-year sales between $64.3 billion and $65.3 billion versus its previous range of $64.1 billion to $65.6 billion. Analysts surveyed by FactSet expect $64.95 billion.